trending Market Intelligence /marketintelligence/en/news-insights/trending/ob8pwmnk3grbw5d2bs2foq2 content esgSubNav
In This List

Verastem Oncology begins $35M common stock offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Verastem Oncology begins $35M common stock offering

Verastem Inc. commenced a public offering of its common stock worth $35 million.

The Needham, Mass.-based biopharmaceutical company granted the underwriter an option to buy up to an additional $5.25 million worth of common shares.

Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering.